检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]青岛市肿瘤医院核医学科,山东青岛266042
出 处:《中国医药科学》2015年第5期128-130,共3页China Medicine And Pharmacy
摘 要:目的探讨肿瘤标志物CYFRA21-1测定对原发性肝癌的诊断价值。方法对原发性肝癌(PHC)组96例、肝良性疾病组52例(肝硬化组28例、乙肝、丙肝组24例)和正常对照组30例,检测血清CYFRA21-1水平并进行统计学分析。结果 PHC组血清CYFRA21-1水平明显高于肝良性疾病组和正常对照组,差异有统计学意义(P<0.01),肝良性疾病组和正常对照组血清CYFRA21-1水平比较差异也有统计学意义(P<0.01),但阳性检出率比较无统计学意义(P>0.05)。PHC组和肝良性疾病组血清CYFRA21-1阳性率分别为66.7%(64/96)、7.7%(4/52)。结论检测血清CYFRA21-1水平对原发性肝癌的监测和诊断有较高的价值。Objective To study the value of tumor marker CYFRA21-1 detection in diagnosis of primary hepatic carcinoma.Methods Choosing three different groups, primary hepatic carcinoma group(96 cases), benign hepatic disease(52 cases) including 28 cases of hepatic cirrhosis and 24 cases of hepatitis b or c, control group(30 cases). Detecting serum level of CYFRA21-1 in the three groups, analyzing data by statistical methods. Results The serum level of CYFRA21-1 in primary hepatic carcinoma group is significantly higher than in benign hepatic disease group or control group(P0.05). The positive rates of CYFRA21-1 detection in primary hepatic carcinoma group and benign hepatic disease are 66.7%(64/96) and 7.7%(4/52). ConclusionDetection serum level of CYFRA21-1 has high value in detecting and diagnosing primary hepatic carcinoma.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117